Literature DB >> 10077561

Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling.

V Doucas1, M Tini, D A Egan, R M Evans.   

Abstract

Disaggregation of the spherical nuclear bodies termed promyelocytic (PML) oncogenic domains (PODs) is a characteristic of acute promyelocytic leukemia. Here, we demonstrate that the cAMP enhancer binding protein (CREB)-binding protein (CBP) associates with PML in vitro and is recruited to the PODs in vivo. Through its association with CBP, wild-type PML dramatically stimulates nuclear receptor transcriptional activity. These results demonstrate that a fraction of CBP is compartmentalized to the POD through its association with PML and thus suggest that PML and other POD-associated proteins may play an unexpectedly broad role in aspects of transcriptional regulation and human disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10077561      PMCID: PMC15819          DOI: 10.1073/pnas.96.6.2627

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  NUCLEAR BODIES: THEIR PREVALENCE, LOCATION, AND ULTRASTRUCTURE IN THE CALF.

Authors:  A F WEBER; S P FROMMES
Journal:  Science       Date:  1963-09-06       Impact factor: 47.728

2.  A retinoic acid-responsive element in the apolipoprotein AI gene distinguishes between two different retinoic acid response pathways.

Authors:  J N Rottman; R L Widom; B Nadal-Ginard; V Mahdavi; S K Karathanasis
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

3.  Recruitment of p300/CBP in p53-dependent signal pathways.

Authors:  M L Avantaggiati; V Ogryzko; K Gardner; A Giordano; A S Levine; K Kelly
Journal:  Cell       Date:  1997-06-27       Impact factor: 41.582

Review 4.  The multifunctional role of the co-activator CBP in transcriptional regulation.

Authors:  P S Goldman; V K Tran; R H Goodman
Journal:  Recent Prog Horm Res       Date:  1997

5.  Synergistic activation of transcription by CBP and p53.

Authors:  W Gu; X L Shi; R G Roeder
Journal:  Nature       Date:  1997-06-19       Impact factor: 49.962

6.  Binding and modulation of p53 by p300/CBP coactivators.

Authors:  N L Lill; S R Grossman; D Ginsberg; J DeCaprio; D M Livingston
Journal:  Nature       Date:  1997-06-19       Impact factor: 49.962

Review 7.  The PML nuclear compartment and cancer.

Authors:  V Doucas; R M Evans
Journal:  Biochim Biophys Acta       Date:  1996-12-09

8.  Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300.

Authors:  H Chen; R J Lin; R L Schiltz; D Chakravarti; A Nash; L Nagy; M L Privalsky; Y Nakatani; R M Evans
Journal:  Cell       Date:  1997-08-08       Impact factor: 41.582

9.  Unique response pathways are established by allosteric interactions among nuclear hormone receptors.

Authors:  B M Forman; K Umesono; J Chen; R M Evans
Journal:  Cell       Date:  1995-05-19       Impact factor: 41.582

10.  Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure.

Authors:  V Doucas; A M Ishov; A Romo; H Juguilon; M D Weitzman; R M Evans; G G Maul
Journal:  Genes Dev       Date:  1996-01-15       Impact factor: 11.361

View more
  51 in total

1.  PML is induced by oncogenic ras and promotes premature senescence.

Authors:  G Ferbeyre; E de Stanchina; E Querido; N Baptiste; C Prives; S W Lowe
Journal:  Genes Dev       Date:  2000-08-15       Impact factor: 11.361

2.  Potentiation of GATA-2 activity through interactions with the promyelocytic leukemia protein (PML) and the t(15;17)-generated PML-retinoic acid receptor alpha oncoprotein.

Authors:  S Tsuzuki; M Towatari; H Saito; T Enver
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

3.  Cytoplasmic catalytic subunit of protein kinase A mediates cross-repression by NF-kappa B and the glucocorticoid receptor.

Authors:  V Doucas; Y Shi; S Miyamoto; A West; I Verma; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

4.  Interaction between the human cytomegalovirus UL82 gene product (pp71) and hDaxx regulates immediate-early gene expression and viral replication.

Authors:  Stacy R Cantrell; Wade A Bresnahan
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

5.  Histone acetyltransferase activity of p300 is required for transcriptional repression by the promyelocytic leukemia zinc finger protein.

Authors:  Fabien Guidez; Louise Howell; Mark Isalan; Marek Cebrat; Rhoda M Alani; Sarah Ivins; Itsaso Hormaeche; Melanie J McConnell; Sarah Pierce; Philip A Cole; Jonathan Licht; Arthur Zelent
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

6.  Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections.

Authors:  Nina Tavalai; Peer Papior; Sabine Rechter; Martina Leis; Thomas Stamminger
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

Review 7.  The checkpoints of viral gene expression in productive and latent infection: the role of the HDAC/CoREST/LSD1/REST repressor complex.

Authors:  Bernard Roizman
Journal:  J Virol       Date:  2011-03-30       Impact factor: 5.103

8.  Human cytomegalovirus (HCMV) UL82 gene product (pp71) relieves hDaxx-mediated repression of HCMV replication.

Authors:  Stacy R Cantrell; Wade A Bresnahan
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

9.  Negative modulation of androgen receptor transcriptional activity by Daxx.

Authors:  Ding-Yen Lin; Hsin-I Fang; Ai-Hong Ma; Yen-Sung Huang; Yeong-Shiau Pu; Guido Jenster; Hsing-Jien Kung; Hsiu-Ming Shih
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

10.  Luman/CREB3 recruitment factor regulates glucocorticoid receptor activity and is essential for prolactin-mediated maternal instinct.

Authors:  Amanda C Martyn; Elena Choleris; Daniel J Gillis; John N Armstrong; Talya R Amor; Adam R R McCluggage; Patricia V Turner; Genqing Liang; Kimberly Cai; Ray Lu
Journal:  Mol Cell Biol       Date:  2012-10-15       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.